WARSAW, July 23, 2021 - Greenberg Traurig acted as legal counsel to a syndicate of investment banks in the public offering of shares in Celon Pharma S.A. (“Celon Pharma”) and the admission of Celon Pharma shares to listing on the Warsaw Stock Exchange.
As part of the SPO, Celon Pharma offered 6 million series D shares at a price of PLN 36. The value of the shares sold in the SPO was PLN 216 million.
Greenberg Traurig advised Dom Maklerski Banku Handlowego S.A. as an investment firm, global coordinator and joint bookrunner, Citigroup Global Markets Europe AG, Erste Group Bank AG and Erste Securities Polska S.A. as global coordinators and joint bookrunners, Jefferies GmbH and Jefferies International Limited, as joint bookrunners, and Trigon Dom Maklerski S.A. as the co-lead managers.
The transaction was led by Partner Rafał Sieński who was supported by Associate Michał Bałdowski and Associate Łukasz Chmura.
Partners Dorothee Fischer-Appelt and James Mountain from Greenberg Traurig’s London Office advised on the US and English law aspects of the SPO, respectively.
Celon Pharma is an integrated biopharmaceutical company which designs, develops, manufactures and distributes pharmaceutical products. The Company's pipeline includes more than a dozen projects for the development of innovative drugs with therapeutic groups such as oncology, neuro-psychiatry, autoimmunity and metabolism. The Company has its own research and development laboratories, which allow it to develop its own pharmaceutical technologies by using extensive laboratory equipment resources, as well as the experience and expertise of its staff. It also has a modern manufacturing facility where dry pharmaceutical forms are manufactured.
Greenberg Traurig is recognized as a longstanding leader in Poland with respect to capital markets, having recently advised the investment banks on the IPO of Allegro. For many years, the Warsaw Capital Markets Practice has been consistently ranked at the very top by leading international directories: Band 1 by Chambers Global, Chambers Europe and the Legal 500, as well as Tier 1 by the IFLR 1000. The Practice offers clients an unparalleled breadth of experience in all aspects of Polish securities law, allowing for the facilitation of all phases of securities transactions on Polish and international capital markets. Greenberg Traurig Warsaw’s seasoned capital markets professionals are acknowledged leaders in Poland and together make up one of the most experienced teams among international law firms in the vibrant Central European market.
Greenberg Traurig LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2200 attorneys serving clients from 40 offices in the United States, Latin America, Europe, Asia, and the Middle East.
Greenberg Traurig Grzesiak sp.k. was named the 2021 Poland Firm of the Year award at the highly esteemed Euromoney Legal Media Group “Women in Business Law Awards 2021 Europe” and the 2021, 2019, 2018 Law Firm of the Year in Poland by International Financial Law Review (IFLR). The Warsaw office of Greenberg Traurig, LLP provides legal services to clients in Central Europe and beyond and consists of approximately 100 lawyers. Team members are regularly recognized as leaders in numerous practice areas. Chambers Global, Chambers Europe, IFLR1000 and EMEA Legal 500 consistently rank them among the top tiers the areas of Corporate/M&A, Capital Markets, Real Estate, Private Equity, Tax, Banking and Finance, Project Finance, Energy, Dispute Resolution and TMT.
For additional information, please visit www.gtlaw.com.